Assaying estrogenicity by quantitating the expression levels of endogenous estrogen-regulated genes

Environmental Health Perspectives

Volumn 108, Issue 5, 2000, Pages 403-412

  Jørgensen, Marianne ^a   Vendelbo, Brian ^a   Skakkebæk, Niels E ^a   Leffers, Henrik ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Competitive PCR; Differential display; Endocrine disruptors; Estrogen; Estrogenicity assay; Gene expression; Monoamine oxidase A; PS2; TGF 3; l antichymotrypsin

Indexed keywords

1,1 DICHLORO 2,2 BIS(4 CHLOROPHENYL)ETHYLENE; 4 HYDROXYTAMOXIFEN; 4,4' ISOPROPYLIDENEDIPHENOL; ALPHA 1 ANTICHYMOTRYPSIN; ALPHA ZEARALENOL; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; DIETHYLSTILBESTROL; ENDOSULFAN; ESTRADIOL; ESTROGEN; FULVESTRANT; GENISTEIN; METHOXYCHLOR; NONYLPHENOL; PHTHALIC ACID DIBUTYL ESTER; PROTEIN PS2; TRANSFORMING GROWTH FACTOR BETA3;

ARTICLE; ASSAY; CHEMICAL INTERACTION; CHEMICAL STRUCTURE; CONTROLLED STUDY; DRUG POTENCY; DRUG SENSITIVITY; ENDOCRINE SYSTEM; ENVIRONMENTAL EXPOSURE; ESTROGEN ACTIVITY; GENE EXPRESSION; GENE INDUCTION; GENE REPRESSION; HUMAN; HUMAN CELL; MARKER GENE; PRIORITY JOURNAL; SCREENING;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0033937303     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.00108403     Document Type: Article

References (65)

1. Kavlock RJ, Daston GP, DeRosa C, Fenner-Crisp P, Gray LE, Kaattari S, Lucier G, Luster M, Mac MJ, Maczka C, et al. Research needs for the risk assessment of health and environmental effects of endocrine disrupters: a report of the U.S. EPA-sponsored workshop. Environ Health Perspect 104(suppl 4):715-740 (1996).
2. Toppari J, Larsen JC, Christiansen P, Giwercman A, Grandjean P, Guillette LJ Jr, Jégou B, Jensen TK, Jouannet P, Keiding N, et al. Male reproductive health and environmental chemicals with estrogenic effects. Environ Health Perspect 104(suppl 4):741-803 (1996).
3. Carlsen E, Giwercman A, Keiding N, Skakkebæk NE. Evidence for decreasing quality of sperm counts during 50 years. Br Med J 305:609-613 (1992).
4. Adami HO, Bergström R, Möhner M, Zatonski W, Storm H, Ekborn A, Tretli S, Teppo L, Ziegler H, Rahu M, et al. Testicular cancer in nine northern European countries. Im J Cancer 59:33-38 (1994).
5. Sharpe RM, Skakkebaek NE. Are estrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet 341:1392-1395 (1993).
6. Henderson BE, Ross RK, Pike MC, Casagrande JT. Endogenous hormones as a major factor in human cancer. Cancer Res 42:3232-3239 (1982).
7. Giwercman A, Skakkebæk NE. The human testis - an organ at risk? [Editorial]. Int J Androl 15:373-375 (1992).
8. Davis DL, Bradlow HL, Wollf M, Woodruff T, Hoel G, Anton-Culver H. Medical hypothesis: xenoestrogens as preventable causes of breast cancer. Environ Health Perspect 101:372-377 (1993).
9. Soto AM, Sonnenschein C, Chung KL, Fernandez MF, Olea N, Serrano FO. The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environ Health Perspect 103(suppl 7):113-122 (1995).
10. Jobling S, Reynolds T, White R, Parker MG, Sumpter JP. A variety of environmentally persistent chemicals, including some phthalate plasticizers, are weakly estrogenic. Environ Health Perspect 103:582-587 (1995).
11. Zava DT, Blen M, Duwe G. Estrogenic activity of natural and synthetic estrogens in human breast cancer cells in culture. Environ Health Perspect 105(suppl 3):637-645 (1997).
12. U.S. Environmental Protection Agency, Office of Science Coordination and Policy. Endocrine Disruptor Screening and Testing Program Website. Available: http:// www.epa.gov/oscpmont/oscpendo/index.htm [cited 14 February 2000].
13. Taylor CM, Blanchard B, Zava DT. A simple method to determine whole cell uptake of radiolabelled oestrogen and progesterone and their subcellular localization in breast cancer cell lines in monolayer culture. J Steroid Biochem 20:1083-1088 (1984).
14. Shafie S, Brooks SC. Characteristics of the dextran-coated charcoal assay for estradiol receptor in breast cancer preparations. J Lab Clin Med 94:784-798 (1979).
15. Klein KO, Baron J, Colli MJ, McDonnell DP, Cutler GB Jr. Estrogen levels in childhood determined by an ultrasensitive recombinant cell bioassay. J Clin Invest 94:2475-2480 (1994).
16. Lan NC, Katzenellenbogen BS. Temporal relationships between hormone receptor binding and biological responses in the uterus: studies with short- and long-acting derivatives of estriol. Endocrinology 98:220-227 (1976).
17. Gray LE Jr, Ostby J, Ferrell J, Rehnberg G, Linder R, Cooper R, Goldman J, Slott V, Laskey J. A dose-response analysis of methoxychlor-induced alterations of reproductive development and function in the rat. Fundam Appl Toxicol 12:92-108 (1989).
18. Sumpter JP, Jobling S. Vitellogenesis as a biomarker for estrogenic contamination of the aquatic environment. Environ Health Perspect 103(suppl 7):173-178 (1995).
19. Andersen HR, Andersson AM, Arnold SF, Autrup H, Barfoed M, Beresford NA, Bjerregaard P, Christiansen LB, Gissel B, Hummel R, et al. Comparison of short-term estrogenicity tests for identification of hormone-disrupting chemicals. Environ Health Perspect 107(suppl 1):89-108 (1999).
20. Jørgensen M, Hummel R, Bévort M, Andersson AM, Skakkebaek NE, Leffers H. Detection of oestrogenic chemicals by assaying the expression level of oestrogen regulated genes. APMIS 106:245-251 (1998).
21. VanderKuur JA, Hafner MS, Christman JK, Brooks SC. Effects of estradiol-17β analogues on activation of estrogen response element regulated chloramphenicol acyltransferase expression. Biochemistry 32:7016-7021 (1993).
22. Meyer T, Koop R, von Angerer E, Schonenberger H, Holler E. A rapid luciferase transfection assay for transcription activation effects and stability control of estrogens in cell culture. J Cancer Res Clin Oncol 120:359-364 (1994).
23. Vinggaard AM, Joergensen ECB, Larsen JC. Rapid and sensitive reporter gene assays for detection of antiandrogenic and estrogenic effects of environmental chemicals. Toxicol Appl Pharmacol 155:150-160 (1999).
24. Andersson AM, Skakkebæk NE. Exposure to exogenous estrogens in food: possible impact on human development and health. Eur J Endocrinol 140:477-485 (1999).
25. Nishikawa J, Saito K, Goto J, Dakeyama F, Matsuo M, Nishihara T. New screening methods for chemicals with hormonal activities using interaction of nuclear hormone receptor with coactivator. Toxicol Appl Pharmacol 154:76-83 (1999).
26. Masamura S, Santner SJ, Heitjan DF, Santen RJ. Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells. J Clin Endocrinol Metab 80:2918-2925 (1995).
27. Gaido KW, Leonard LS, Lovell S, Gould JC, Babaï D, Portier CJ, McDonnell DP. Evaluation of chemicals with endocrine modulating activity in a yeast-based steroid hormone receptor gene transcription assay. Toxicol Appl Pharmacol 143:205-212 (1997).
28. Bolger R, Wiese TE, Ervin K, Nestich S, Checovich W. Rapid screening of environmental chemicals for estrogen receptor binding capacity. Environ Health Perspect 106:551-557 (1998).
29. Petit F, Le Goff P, Cravédi JP, Valotaire Y, Pakdel F. Two complementary bioassays for screening the estrogenic potency of xenobiotics: recombinant yeast for trout estrogen receptor and trout hepatocyre cultures. J Mol Endocrinol 19:321-335 (1997).
30. Liang P, Pardee AB. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257:967-971 (1992).
31. Jørgensen M, Bévort M, Kledal TS, Dalgaard M, Leffers H. Differential display competitive polymerase chain reaction: an optimal tool for assaying gene expression. Electrophoresis 20:230-240 (1999).
32. Leffers H, DD Base Homepage. Available: http:// www.biobase.dk/~ddbase/ [cited 14 February 2000].
33. Darbre P, Yates J, Curtis S, King RJB. Effect of estradiol on human breast cancer cells in culture. Cancer Res 43:349-354 (1983).
34. Voss H, Nentwich U, Duthie S, Wiemann S, Benes V, Zimmermann J, Ansorge W. Automated cycle sequencing with Taquenase: protocols for internal labeling, dye primer and "doublex" simultaneous sequencing Biotechniques 23:312-318 (1997).
35. Jørgensen M, Vendelbo B, Skakkebæk NE, Leffers H. Unpublished data.
36. Fields C, Adams MD, White O, Venter JC. How many genes in the human genome? Nat Genet 7:345-346 (1994).
37. Jakowlew SB, Breathnach R, Jeltsch JM, Masiakowski P, Chambon P. Sequence of the pS2 mRNA induced by estrogen in the human breast cancer cell line MCF-7. Nucleic Acids Res 12:2861-2878 (1984).
38. Orlando C, Pinzani P, Pazzagli M. Developments in quantitative PCR. Clin Chem Lab Med 36:255-269 (1998).
39. Santagati S, Garnier M, Carlo P, Violani E, Picotti GB, Maggi A. Quantitation of low abundance mRNAs in glial cells using different polymerase chain reaction (PCR)-based methods. Brain Res Brain Res Protoc 1:217-223 (1997).
40. Rio MC. What is/are the function(s) of trefoil peptides? Bull Cancer 84:443-446 (1997).
41. Taupin D, Wu D-C, Jeon W-K, Devaney K, Wang TC, Podolsky DK. The trefoil gene family are coordinately expressed immediate-early genes: EGF receptor- and MAP kinase-dependent interregulation. J Clin Invest 103:R31-R38 (1999).
42. Jeltsch JM, Roberts M, Schatz C, Gamier JM, Brown AMC, Chambon P. Structure of the human oestrogen-responsive gene pS2 Nucleic Acids Res 15:1401-1414 (1987).
43. Berry M, Nunez AM, Chambon P. Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence. Proc Natl Acad Sci USA 86:1218-1222 (1989).
44. El Ashry D, Chrysogelos SA, Lippman ME, Kern FG. Estrogen induction of TGF-alpha is mediated by an estrogen response element composed of two imperfect palindromes. J Steroid Biochem Mol Biol 59:261-269 (1996).
45. Wang F, Porter W, Xing W, Archer TK, Safe S. Identification of a functional imperfect estrogen-responsive element in the 5′-promoter region of the human cathepsin D gene. Biochemistry 36:7793-7801 (1997).
46. Kraus WL, Montano MM, Katzenellenbogen BS. Identification of multiple, widely spaced estrogen-responsive regions in the rat progesterone receptor gene. Mol Endocrinol 8:952-969 (1994).
47. Wahli W, Martinez E, Corthésy B, Cardinaux JR. cis- and trans-acting elements of the estrogen-regulated vitellogenin gene B1 of Xenopus laevis. J Steroid Biochem 34:17-32 (1989).
48. Ma ZQ, Bondiolotti DM, Olasmaa M, Violani E, Patrone C, Pigotti GB, Maggi A. Estrogen modulation of catecholamine synthesis and monoamine oxidase A activity in the human neuroblastoma cell line SK-ER3. J Steroid Biochem Mol Biol 47:207-211 (1993).
49. Ma ZQ, Violani E, Villa F, Picotti GB, Maggi A. Estrogenic control of monoamine oxidase A activity in human neuroblastoma cells expressing physiological concentrations of estrogen receptor. Eur J Pharmacol 284:171-176 (1995).
50. Holschneider DP, Kumazawa T, Chen K, Shin JC. Tissue-specific effects of estrogen on monoamine oxidase A and B in the rat. Life Sci 53:155-160 (1998).
51. Klaiber EL, Broverman DM, Vogel W, Peterson LG, Snyder MB. Individual differences in changes in mood and platelet monoamine oxidase (MAO) activity during hormonal replacement therapy in menopausal women. Psychoneuroendocrinology 21:575-592 (1996).
52. Klaiber EL, Broverman DM, Vogel W, Peterson LG, Snyder MB. Relationships of serum estradiol levels, menopausal duration, and mood during hormonal replacement therapy. Psychoneuroendocrinology 22:549-558 (1937).
53. Chakravorty SG, Halbreich U. The influence of estrogen on monoamine oxidase activity. Psychopharmacol Bull 33:229-233 (1997).
54. Sarabia SF, Liehr JG. Induction of monoamine oxidase B by 17 beta-estradiol in the hamster kidney preceding carcinogenesis. Arch Biochem Biophys 355:249-253 (1998).
55. Bates SE, Davidson NE, Valverius EM, Freter CE, Dickson RB, Tam JP, Kudlow JE, Lippman ME, Salomon DS. Expression of transforming growth factor alpha and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance. Mol Endocrinol 2:543-555 (1988).
56. Takahashi T, Eitzman B, Bossert NL, Walmer D, Sparrow K, Flanders KC, McLachlan J, Nelson KG. Transforming growth factors beta 1, beta 2, and beta 3 messenger RNA and protein expression in mouse uterus and vagina during estrogen-induced growth: a comparison to other estrogen-regulated genes. Cell Growth Differ 5:919-935 (1994).
57. Dannecker C, Possinger K, Classen S. Induction of TGF-beta by an antiprogestin in the human breast cancer cell line T-47D. Ann Oncol 7:391-395 (1996).
58. Knabbe C, Lippman ME, Wakefield LM, Flanders KC, Kasid A, Derynck R, Dickson RB. Evidence that transforming growth factor β is a hormonally regulated negative growth factor in human breast cancer cells. Cell 48:417-428 (1987).
59. Derynck R, Lindquist PB, Lee A, Wen D, Tamm J, Graycar JL, Rhee L, Mason AJ, Miller DA, Coffey RJ, et al. A new type of transforming growth factor-beta, TGF-beta 3. EMBO J 7:3737-3743 (1988).
60. Massot O, Baskevitch PP, Capony F, Garcia M, Rochefort H. Estradiol increases the production of alpha 1-antichymotrypsin in MCF7 and T47D human breast cancer cell lines. Mol Cell Endocrinol 42:207-214 (1985).
61. Krøll J, Briand P. Estrogen-dependent release of serum proteins from MCF-7 breast carcinoma cells in vitro. Anticancer Res 8:89-91 (1998).
62. Blumberg B, Evans RM. Orphan nuclear receptors - new ligands and new possibilities. Genes Develop 12:3149-3155 (1998).
63. Dowsett M, Macaulay V, Gledhill J, Ryde C, Nicholls J, Ashworth A, McKinna JA, Smith IE. Control of aromatase in breast cancer cells and its importance for tumor growth. J Steroid Biochem Mol Biol 44:605-609 (1993).
64. Bowtell DDL. Options available - from start to finish - for obtaining expression data by microarray. Nat Genet 21(suppl 1):25-32 (1999).
65. Debouck C, Goodfellow PN. DNA microarrays in drug discovery and development. Nat Genet 21(suppl 1):48-50 (1999).